RecruitingNot Applicable

Epidemiology and Prognostic Analysis of Chinese Cancer Patients With Cancer-related Fatigue

China1,000,000 participantsStarted 2025-01-17

Plain-language summary

This investigator-initiated study aims to evaluate the incidence and severity of cancer-related fatigue (CRF) in patients with malignant tumors, to analyze the influencing factors of CRF, and to explore its impact on anti-tumor treatment and prognosis.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Male or female, aged 18 years or older.
. Able to understand the purpose of this survey study, willing to participate, and able to sign an informed consent form.
. Malignant tumor confirmed histologically or cytologically.

Exclusion criteria

. Pregnant or breastfeeding women.
. Patients with acute or chronic infections, or those with other serious medical conditions that, in the investigator's judgment, make them unsuitable for this study.
. Patients with two or more concurrent malignant tumors (excluding the following: cured basal cell carcinoma of the skin, carcinoma in situ of the cervix, and papillary thyroid carcinoma).
. Patients with psychiatric illness or mental disorders, poor compliance, or who are unable to cooperate and report treatment responses.
. Patients with severe organic disease or major organ failure, such as decompensated heart, lung, liver, or kidney failure.
. Patients with other conditions that, in the investigator's opinion, make them unsuitable for participation in this study.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

The incidence of cancer-related fatigue (CRF) in tumor patients.

Timeframe: Baseline

Trial details

NCT IDNCT07656324

SponsorFudan University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2027-01-17

Contact for this trial

Hongxia Wang, PhD

021-33988888 whx365@126.com

View on ClinicalTrials.gov More Cancer trials